MitoRx Publishes Study on AP39’s Effectiveness in Reducing Obesity
MitoRx Therapeutics has published a study in Pharmacological Research demonstrating that its mitochondrial-targeted sulfide-donor compound, AP39, significantly reduces weight gain and fatty liver. This study is the first to explore the potential of mitochondrial sulfide donors in addressing obesity-related disorders.
More
Connecting our community through The Wire – a new digital platform for innovators
We’re excited to share that Oxford Innovation Space has launched The Wire – a brand-new digital platform created to connect more than 900 businesses across the UK and Ireland that call our innovation centres home. As part of the Oxford Innovation Space network, businesses based here at The Harwell Innovation […]
Immigration law firm Migrate UK relocates to Harwell Campus
Migrate UK has relocated to Harwell Campus, a science and innovation park just outside Chilton that is home to more than 200 organisations. It also hosts 14 leading facilities, including the European Space Agency’s European satellite and space telecommunications centre. Migrate UK’s 12-strong team has joined other businesses at […]
Harwell Innovation Centre celebrates 25 years of powering science and technology innovation
Playing a supporting role in the UK’s innovation economy, we at Harwell Innovation Centre in Oxfordshire marked our 25th anniversary on Wednesday (11 June 2025) with a special event honouring the early-stage businesses we have helped nurture – many of which are now leading breakthroughs in energy, space, health and quantum computing. […]
